chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Acidosis, Acute kidney injury, Angiogram abnormal, Angiogram pulmonary abnormal, Blood culture positive
Clinical narrative: Patient is a 72 y.o. female with PMHx significant for CAD, HTN, HLD, COPD, tobacco use disorder, vitamin D deficiency, and insomnia who presented to DH on 1/12/2023 with syncopal episode.  Initial work-up concerning for septic shock secondary to underlying colitis.  There was initially concern for C. difficile colitis and patient was on oral vancomycin and IV Flagyl due to possibility of fulminant C. difficile.  Patient was also briefly on a bicarb drip due to worsening AKI and acidosis.  Patient was found to be COVID-positive, but without COVID-pneumonia.  Infectious disease was consulted and started the patient on remdesivir.  C. difficile testing and stool PCR testing came back negative and patient was transitioned to Vanco and Zosyn. However, due to no obvious infectious etiology, antibiotics were initially discontinued. Subsequently 1/2 Bcx turned out to be positive for GNB without any further confirmation. Patient was there fore treated with IV antibiotic and transition to oral for total 7 days as recommended by infectious disease. Patient has finished remdesivir, improved respiratory status, on RA, diarrhea resolved, ambulating on her own with plans to discharge home with family.    Septic versus hypovolemic shock-resolved Diarrhea Off pressors, BP stable. AF, on RA LA 4.6>1.7. Leukocytosis at 16>13K CTA C/A/P suggestive of possible diffuse colitis. C. difficile testing and stool PCR negative, blood cultures negative today  Imodium prn given ongoing diarrhea. Diarrhea improving BP stable, good urine output Discontinued IV fluid stable   COVID-19 infection Suspect incidental COVID infection, on RA COVID test + on 1/12/23 Not requiring oxygen and no pulmonary infiltrates on CT Procal markedly elevated at 86.5 finished remdesivir per ID recommendations Improved overall   Positive blood culture 1/2  GNB 1/12 Unclear significance, ID PCR inconclusive Clinically looks better, afebrile, no leukocytosis Abx transitioned to Augmentin for 5 more days per ID. Anemia normocytic normochromic Hb on arrival at 12.1>10.7>7.3 Check iron panel and stool occult. Transfuse for Hb <7.0 No active bleeding at this time Iron studies consistent with iron deficiency anemia Patient not allergic to iron,  discussed with her IV iron x  3 doses Outpatient work up for anemia Hgb stable at 7.7  B12 and folate adequate   Hyperlipidemia Lipids 6/20/2022: TC 179, TG 79, HDL 89, LDL 74 Continue home atorvastatin 80 mg daily  Hypertension Home medications: Amlodipine 2.5 mg daily and losartan 25 mg daily BP meds held in the setting of shock BP now elevated Resumed amlodipine at 5 mg daily 1/16 BP elevated, resumed losartan 1/17 Increased Losartan to 50 mg daily for better BP control  Vitamin D deficiency Vitamin D 6/20/2022: 22 Ergocalciferol 50,000 units weekly   Insomnia Continue home zolpidem as needed   Tobacco abuse On Chantix at home Encourage continued cessation
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood folate normal, Blood pressure increased, COVID-19, Clostridium test negative, Colitis
Clinical narrative: Patient is a 72 y.o. female with PMHx significant for CAD, HTN, HLD, COPD, tobacco use disorder, vitamin D deficiency, and insomnia who presented to DH on 1/12/2023 with syncopal episode.  Initial work-up concerning for septic shock secondary to underlying colitis.  There was initially concern for C. difficile colitis and patient was on oral vancomycin and IV Flagyl due to possibility of fulminant C. difficile.  Patient was also briefly on a bicarb drip due to worsening AKI and acidosis.  Patient was found to be COVID-positive, but without COVID-pneumonia.  Infectious disease was consulted and started the patient on remdesivir.  C. difficile testing and stool PCR testing came back negative and patient was transitioned to Vanco and Zosyn. However, due to no obvious infectious etiology, antibiotics were initially discontinued. Subsequently 1/2 Bcx turned out to be positive for GNB without any further confirmation. Patient was there fore treated with IV antibiotic and transition to oral for total 7 days as recommended by infectious disease. Patient has finished remdesivir, improved respiratory status, on RA, diarrhea resolved, ambulating on her own with plans to discharge home with family.    Septic versus hypovolemic shock-resolved Diarrhea Off pressors, BP stable. AF, on RA LA 4.6>1.7. Leukocytosis at 16>13K CTA C/A/P suggestive of possible diffuse colitis. C. difficile testing and stool PCR negative, blood cultures negative today  Imodium prn given ongoing diarrhea. Diarrhea improving BP stable, good urine output Discontinued IV fluid stable   COVID-19 infection Suspect incidental COVID infection, on RA COVID test + on 1/12/23 Not requiring oxygen and no pulmonary infiltrates on CT Procal markedly elevated at 86.5 finished remdesivir per ID recommendations Improved overall   Positive blood culture 1/2  GNB 1/12 Unclear significance, ID PCR inconclusive Clinically looks better, afebrile, no leukocytosis Abx transitioned to Augmentin for 5 more days per ID. Anemia normocytic normochromic Hb on arrival at 12.1>10.7>7.3 Check iron panel and stool occult. Transfuse for Hb <7.0 No active bleeding at this time Iron studies consistent with iron deficiency anemia Patient not allergic to iron,  discussed with her IV iron x  3 doses Outpatient work up for anemia Hgb stable at 7.7  B12 and folate adequate   Hyperlipidemia Lipids 6/20/2022: TC 179, TG 79, HDL 89, LDL 74 Continue home atorvastatin 80 mg daily  Hypertension Home medications: Amlodipine 2.5 mg daily and losartan 25 mg daily BP meds held in the setting of shock BP now elevated Resumed amlodipine at 5 mg daily 1/16 BP elevated, resumed losartan 1/17 Increased Losartan to 50 mg daily for better BP control  Vitamin D deficiency Vitamin D 6/20/2022: 22 Ergocalciferol 50,000 units weekly   Insomnia Continue home zolpidem as needed   Tobacco abuse On Chantix at home Encourage continued cessation
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Diarrhoea, Haemoglobin decreased, High density lipoprotein normal, Hyperlipidaemia
Clinical narrative: Patient is a 72 y.o. female with PMHx significant for CAD, HTN, HLD, COPD, tobacco use disorder, vitamin D deficiency, and insomnia who presented to DH on 1/12/2023 with syncopal episode.  Initial work-up concerning for septic shock secondary to underlying colitis.  There was initially concern for C. difficile colitis and patient was on oral vancomycin and IV Flagyl due to possibility of fulminant C. difficile.  Patient was also briefly on a bicarb drip due to worsening AKI and acidosis.  Patient was found to be COVID-positive, but without COVID-pneumonia.  Infectious disease was consulted and started the patient on remdesivir.  C. difficile testing and stool PCR testing came back negative and patient was transitioned to Vanco and Zosyn. However, due to no obvious infectious etiology, antibiotics were initially discontinued. Subsequently 1/2 Bcx turned out to be positive for GNB without any further confirmation. Patient was there fore treated with IV antibiotic and transition to oral for total 7 days as recommended by infectious disease. Patient has finished remdesivir, improved respiratory status, on RA, diarrhea resolved, ambulating on her own with plans to discharge home with family.    Septic versus hypovolemic shock-resolved Diarrhea Off pressors, BP stable. AF, on RA LA 4.6>1.7. Leukocytosis at 16>13K CTA C/A/P suggestive of possible diffuse colitis. C. difficile testing and stool PCR negative, blood cultures negative today  Imodium prn given ongoing diarrhea. Diarrhea improving BP stable, good urine output Discontinued IV fluid stable   COVID-19 infection Suspect incidental COVID infection, on RA COVID test + on 1/12/23 Not requiring oxygen and no pulmonary infiltrates on CT Procal markedly elevated at 86.5 finished remdesivir per ID recommendations Improved overall   Positive blood culture 1/2  GNB 1/12 Unclear significance, ID PCR inconclusive Clinically looks better, afebrile, no leukocytosis Abx transitioned to Augmentin for 5 more days per ID. Anemia normocytic normochromic Hb on arrival at 12.1>10.7>7.3 Check iron panel and stool occult. Transfuse for Hb <7.0 No active bleeding at this time Iron studies consistent with iron deficiency anemia Patient not allergic to iron,  discussed with her IV iron x  3 doses Outpatient work up for anemia Hgb stable at 7.7  B12 and folate adequate   Hyperlipidemia Lipids 6/20/2022: TC 179, TG 79, HDL 89, LDL 74 Continue home atorvastatin 80 mg daily  Hypertension Home medications: Amlodipine 2.5 mg daily and losartan 25 mg daily BP meds held in the setting of shock BP now elevated Resumed amlodipine at 5 mg daily 1/16 BP elevated, resumed losartan 1/17 Increased Losartan to 50 mg daily for better BP control  Vitamin D deficiency Vitamin D 6/20/2022: 22 Ergocalciferol 50,000 units weekly   Insomnia Continue home zolpidem as needed   Tobacco abuse On Chantix at home Encourage continued cessation
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hypovolaemic shock, Leukocytosis, Lipids, Low density lipoprotein normal, Normochromic normocytic anaemia
Clinical narrative: Patient is a 72 y.o. female with PMHx significant for CAD, HTN, HLD, COPD, tobacco use disorder, vitamin D deficiency, and insomnia who presented to DH on 1/12/2023 with syncopal episode.  Initial work-up concerning for septic shock secondary to underlying colitis.  There was initially concern for C. difficile colitis and patient was on oral vancomycin and IV Flagyl due to possibility of fulminant C. difficile.  Patient was also briefly on a bicarb drip due to worsening AKI and acidosis.  Patient was found to be COVID-positive, but without COVID-pneumonia.  Infectious disease was consulted and started the patient on remdesivir.  C. difficile testing and stool PCR testing came back negative and patient was transitioned to Vanco and Zosyn. However, due to no obvious infectious etiology, antibiotics were initially discontinued. Subsequently 1/2 Bcx turned out to be positive for GNB without any further confirmation. Patient was there fore treated with IV antibiotic and transition to oral for total 7 days as recommended by infectious disease. Patient has finished remdesivir, improved respiratory status, on RA, diarrhea resolved, ambulating on her own with plans to discharge home with family.    Septic versus hypovolemic shock-resolved Diarrhea Off pressors, BP stable. AF, on RA LA 4.6>1.7. Leukocytosis at 16>13K CTA C/A/P suggestive of possible diffuse colitis. C. difficile testing and stool PCR negative, blood cultures negative today  Imodium prn given ongoing diarrhea. Diarrhea improving BP stable, good urine output Discontinued IV fluid stable   COVID-19 infection Suspect incidental COVID infection, on RA COVID test + on 1/12/23 Not requiring oxygen and no pulmonary infiltrates on CT Procal markedly elevated at 86.5 finished remdesivir per ID recommendations Improved overall   Positive blood culture 1/2  GNB 1/12 Unclear significance, ID PCR inconclusive Clinically looks better, afebrile, no leukocytosis Abx transitioned to Augmentin for 5 more days per ID. Anemia normocytic normochromic Hb on arrival at 12.1>10.7>7.3 Check iron panel and stool occult. Transfuse for Hb <7.0 No active bleeding at this time Iron studies consistent with iron deficiency anemia Patient not allergic to iron,  discussed with her IV iron x  3 doses Outpatient work up for anemia Hgb stable at 7.7  B12 and folate adequate   Hyperlipidemia Lipids 6/20/2022: TC 179, TG 79, HDL 89, LDL 74 Continue home atorvastatin 80 mg daily  Hypertension Home medications: Amlodipine 2.5 mg daily and losartan 25 mg daily BP meds held in the setting of shock BP now elevated Resumed amlodipine at 5 mg daily 1/16 BP elevated, resumed losartan 1/17 Increased Losartan to 50 mg daily for better BP control  Vitamin D deficiency Vitamin D 6/20/2022: 22 Ergocalciferol 50,000 units weekly   Insomnia Continue home zolpidem as needed   Tobacco abuse On Chantix at home Encourage continued cessation
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Shock, Stool analysis normal, Syncope
Clinical narrative: Patient is a 72 y.o. female with PMHx significant for CAD, HTN, HLD, COPD, tobacco use disorder, vitamin D deficiency, and insomnia who presented to DH on 1/12/2023 with syncopal episode.  Initial work-up concerning for septic shock secondary to underlying colitis.  There was initially concern for C. difficile colitis and patient was on oral vancomycin and IV Flagyl due to possibility of fulminant C. difficile.  Patient was also briefly on a bicarb drip due to worsening AKI and acidosis.  Patient was found to be COVID-positive, but without COVID-pneumonia.  Infectious disease was consulted and started the patient on remdesivir.  C. difficile testing and stool PCR testing came back negative and patient was transitioned to Vanco and Zosyn. However, due to no obvious infectious etiology, antibiotics were initially discontinued. Subsequently 1/2 Bcx turned out to be positive for GNB without any further confirmation. Patient was there fore treated with IV antibiotic and transition to oral for total 7 days as recommended by infectious disease. Patient has finished remdesivir, improved respiratory status, on RA, diarrhea resolved, ambulating on her own with plans to discharge home with family.    Septic versus hypovolemic shock-resolved Diarrhea Off pressors, BP stable. AF, on RA LA 4.6>1.7. Leukocytosis at 16>13K CTA C/A/P suggestive of possible diffuse colitis. C. difficile testing and stool PCR negative, blood cultures negative today  Imodium prn given ongoing diarrhea. Diarrhea improving BP stable, good urine output Discontinued IV fluid stable   COVID-19 infection Suspect incidental COVID infection, on RA COVID test + on 1/12/23 Not requiring oxygen and no pulmonary infiltrates on CT Procal markedly elevated at 86.5 finished remdesivir per ID recommendations Improved overall   Positive blood culture 1/2  GNB 1/12 Unclear significance, ID PCR inconclusive Clinically looks better, afebrile, no leukocytosis Abx transitioned to Augmentin for 5 more days per ID. Anemia normocytic normochromic Hb on arrival at 12.1>10.7>7.3 Check iron panel and stool occult. Transfuse for Hb <7.0 No active bleeding at this time Iron studies consistent with iron deficiency anemia Patient not allergic to iron,  discussed with her IV iron x  3 doses Outpatient work up for anemia Hgb stable at 7.7  B12 and folate adequate   Hyperlipidemia Lipids 6/20/2022: TC 179, TG 79, HDL 89, LDL 74 Continue home atorvastatin 80 mg daily  Hypertension Home medications: Amlodipine 2.5 mg daily and losartan 25 mg daily BP meds held in the setting of shock BP now elevated Resumed amlodipine at 5 mg daily 1/16 BP elevated, resumed losartan 1/17 Increased Losartan to 50 mg daily for better BP control  Vitamin D deficiency Vitamin D 6/20/2022: 22 Ergocalciferol 50,000 units weekly   Insomnia Continue home zolpidem as needed   Tobacco abuse On Chantix at home Encourage continued cessation
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vitamin B12 normal, White blood cell count increased
Clinical narrative: Patient is a 72 y.o. female with PMHx significant for CAD, HTN, HLD, COPD, tobacco use disorder, vitamin D deficiency, and insomnia who presented to DH on 1/12/2023 with syncopal episode.  Initial work-up concerning for septic shock secondary to underlying colitis.  There was initially concern for C. difficile colitis and patient was on oral vancomycin and IV Flagyl due to possibility of fulminant C. difficile.  Patient was also briefly on a bicarb drip due to worsening AKI and acidosis.  Patient was found to be COVID-positive, but without COVID-pneumonia.  Infectious disease was consulted and started the patient on remdesivir.  C. difficile testing and stool PCR testing came back negative and patient was transitioned to Vanco and Zosyn. However, due to no obvious infectious etiology, antibiotics were initially discontinued. Subsequently 1/2 Bcx turned out to be positive for GNB without any further confirmation. Patient was there fore treated with IV antibiotic and transition to oral for total 7 days as recommended by infectious disease. Patient has finished remdesivir, improved respiratory status, on RA, diarrhea resolved, ambulating on her own with plans to discharge home with family.    Septic versus hypovolemic shock-resolved Diarrhea Off pressors, BP stable. AF, on RA LA 4.6>1.7. Leukocytosis at 16>13K CTA C/A/P suggestive of possible diffuse colitis. C. difficile testing and stool PCR negative, blood cultures negative today  Imodium prn given ongoing diarrhea. Diarrhea improving BP stable, good urine output Discontinued IV fluid stable   COVID-19 infection Suspect incidental COVID infection, on RA COVID test + on 1/12/23 Not requiring oxygen and no pulmonary infiltrates on CT Procal markedly elevated at 86.5 finished remdesivir per ID recommendations Improved overall   Positive blood culture 1/2  GNB 1/12 Unclear significance, ID PCR inconclusive Clinically looks better, afebrile, no leukocytosis Abx transitioned to Augmentin for 5 more days per ID. Anemia normocytic normochromic Hb on arrival at 12.1>10.7>7.3 Check iron panel and stool occult. Transfuse for Hb <7.0 No active bleeding at this time Iron studies consistent with iron deficiency anemia Patient not allergic to iron,  discussed with her IV iron x  3 doses Outpatient work up for anemia Hgb stable at 7.7  B12 and folate adequate   Hyperlipidemia Lipids 6/20/2022: TC 179, TG 79, HDL 89, LDL 74 Continue home atorvastatin 80 mg daily  Hypertension Home medications: Amlodipine 2.5 mg daily and losartan 25 mg daily BP meds held in the setting of shock BP now elevated Resumed amlodipine at 5 mg daily 1/16 BP elevated, resumed losartan 1/17 Increased Losartan to 50 mg daily for better BP control  Vitamin D deficiency Vitamin D 6/20/2022: 22 Ergocalciferol 50,000 units weekly   Insomnia Continue home zolpidem as needed   Tobacco abuse On Chantix at home Encourage continued cessation
Age: 36.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired Vaccine Administration. No Adverse Symptoms Reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Coronary artery occlusion, Dyspepsia, Loss of consciousness
Clinical narrative: 100% blockage in the right coronary artery .  Symptoms: heartburn type pain, passed out, pain from chest around right shoulder
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Myocardial infarction
Clinical narrative: 100% blockage in the right coronary artery .  Symptoms: heartburn type pain, passed out, pain from chest around right shoulder
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: PATIENT RECEIVED PFIZER BIVALENT VACCINE ON 12/28/22 BUT HAD ALREADY RECEIVED A BIVALENT DOSE ON 11/1/22 FROM ANOTHER PHARMACY.  IT WAS NOT REPORTED ON IMMPRINT BY THE OTHER PHARMACY PROVIDER UNTIL 12/26/22, WHICH WAS AFTER IMMPRINT WAS CHECKED TO APPROVE THE DOSE ON 12/28.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/1/21 Lot# 010A21A;  Moderna 3/29/21 Lot# 018B21A;  Moderna 10/31/21 Lot# 939905
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines pfizer 2/24/21 Lot# EN6202;  Pfizer 3/17/21 Lot# En6204;  Pfizer 9/24/21 Lot# FF2588;  Pfizer 7/9/22 Lot# FP7150;  Pfizer 9/14/22 Lot# GH9702
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Pfizer 1/16/21 Lot# EL3249;  Pfizer 2/6/21 Lo# EM9810;  Moderna 8/18/21 Lot# 040C21A;  Moderna 4/14/22 Lot# 056M21A; Pfizer  9/23/22 Lot# GH9703
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose normal, Blood test normal, Blood uric acid normal, Fatigue
Clinical narrative: 30 mins after receiving the COVID vaccine I  feel tired all the time, I kneeled down and then I stand up and walked to the walk to lean on the wall for 1-2 mins. then I felt like I can walk so I walked to my car so I can drive home and laid down on my back. Since Oct. I always feel tired and before that I was fine. Now I feel like I lost my energy. I use to play tennis but since the vaccine I don't do it any more.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities
Clinical narrative: 30 mins after receiving the COVID vaccine I  feel tired all the time, I kneeled down and then I stand up and walked to the walk to lean on the wall for 1-2 mins. then I felt like I can walk so I walked to my car so I can drive home and laid down on my back. Since Oct. I always feel tired and before that I was fine. Now I feel like I lost my energy. I use to play tennis but since the vaccine I don't do it any more.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 88.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Moderna 3/1/21 Lot# 015M20A;  Moderna 3/29/21 Lot# 002B21A;  Moderna 10/26/21 Lot# 077C21B;  Moderna 6/24/22 Lot# 005M21A;  Moderna 10/14/22 Lot# 030G22B
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 1/23/21 Lot# 026L20A;  Moderna 2/23/21 Lot# 031L20A; Moderna 11/26/21 Lot# 039F21A;  Moderna 7/28/22 Lot# 016B22A
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 2/4/21 Lot# 007M20A ; Moderna 3/6/21 Lot# 015M20A;  MOderna 10/30/21 Lot# 039F21A;  MOderna 11/5/22 Lot# 016H22A
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: shingles twice
Age: 4.0
Sex: F
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: VACCINE EXPIRED 02/16/23
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/13/21 Lot# 038A21A;  MOderna 4/10/21 Lot# 037B21A;  Moderna 2/17/22 Lot# 083J21A
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Cough, Diarrhoea, Fatigue
Clinical narrative: I was very tired and had no energy when I had COVID-19. I had cough, sore throat, fever, and long-standing diarrhea. I was prescribed PAXLOVID, but I took it for only one day, because I thought that it was what was causing my diarrhea. I'm still in the process of getting over it, and it has already been two weeks. I took some ADVIL for the fever and MUCINEX for the congestion. They were pretty effective.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I was very tired and had no energy when I had COVID-19. I had cough, sore throat, fever, and long-standing diarrhea. I was prescribed PAXLOVID, but I took it for only one day, because I thought that it was what was causing my diarrhea. I'm still in the process of getting over it, and it has already been two weeks. I took some ADVIL for the fever and MUCINEX for the congestion. They were pretty effective.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atelectasis, Benign prostatic hyperplasia, Bronchitis, Burning sensation
Clinical narrative: Patient is a 89 y.o. male patient of MD with history of COPD, morbid obesity, PAF, prostate cancer, OSA on CPAP presented to Hospital with shortness of breath . Assessment and Plan   Acute respiratory failure with hypoxia Due to COVID-19/ Pneumonia and acute COPD exacerbation Management as mentioned below Required 2 L of oxygen on exertion on home o2 eval    Acute Exacerbation of COPD Pneumonia/ Bronchitis Previous PFTs: 12/9/2019 moderate severe obstruction with mild restriction Chest x-ray-atelectasis in the left lung base, normal procalcitonin but sputum cultures grew MRSA and Strep Started on antibiotics Omnicef and Doxy and cont at dc Cont Duoneb, Symbicort. Decadron to complete the course Incentive spirometry every 4, Mucinex twice daily, Tessalon 100 mg as needed Cont home CPAP    Covid-19 Virus Infection Date of onset of symptoms: 1/25/2023 Symptoms present on admission: Cough, Dyspnea, fatigue Date of covid positive test: 1/25/2023, rapid test at facility.  Requested copy of the test Vaccination status: vaccinated Imaging: Mild atelectasis/infiltrate with fluid suggested in the left lung base.  Oxygen requirements on admission: 2 L NC Current oxygen requirements: 2 L NC Medical therapy: steroids complete total of 7 days Ok to complete home paxlovid Consultants following: None at this time Anticipated special isolation end date: TBD  Lasix 20 mg x 1 given for dry lung strategy      BPH Abnormal urinalysis History of prostate cancer Complaining of burning, frequency and urgency in urination UA was sent after ceftriaxone, noted microscopic blood in the urine possibly due to UTI Complete antibiotics as mentioned above  History of PAF Not on rate controlling medicines, continue Eliquis  OSA Continue CPAP
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Patient is a 89 y.o. male patient of MD with history of COPD, morbid obesity, PAF, prostate cancer, OSA on CPAP presented to Hospital with shortness of breath . Assessment and Plan   Acute respiratory failure with hypoxia Due to COVID-19/ Pneumonia and acute COPD exacerbation Management as mentioned below Required 2 L of oxygen on exertion on home o2 eval    Acute Exacerbation of COPD Pneumonia/ Bronchitis Previous PFTs: 12/9/2019 moderate severe obstruction with mild restriction Chest x-ray-atelectasis in the left lung base, normal procalcitonin but sputum cultures grew MRSA and Strep Started on antibiotics Omnicef and Doxy and cont at dc Cont Duoneb, Symbicort. Decadron to complete the course Incentive spirometry every 4, Mucinex twice daily, Tessalon 100 mg as needed Cont home CPAP    Covid-19 Virus Infection Date of onset of symptoms: 1/25/2023 Symptoms present on admission: Cough, Dyspnea, fatigue Date of covid positive test: 1/25/2023, rapid test at facility.  Requested copy of the test Vaccination status: vaccinated Imaging: Mild atelectasis/infiltrate with fluid suggested in the left lung base.  Oxygen requirements on admission: 2 L NC Current oxygen requirements: 2 L NC Medical therapy: steroids complete total of 7 days Ok to complete home paxlovid Consultants following: None at this time Anticipated special isolation end date: TBD  Lasix 20 mg x 1 given for dry lung strategy      BPH Abnormal urinalysis History of prostate cancer Complaining of burning, frequency and urgency in urination UA was sent after ceftriaxone, noted microscopic blood in the urine possibly due to UTI Complete antibiotics as mentioned above  History of PAF Not on rate controlling medicines, continue Eliquis  OSA Continue CPAP
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Dysuria, Fatigue, Micturition urgency
Clinical narrative: Patient is a 89 y.o. male patient of MD with history of COPD, morbid obesity, PAF, prostate cancer, OSA on CPAP presented to Hospital with shortness of breath . Assessment and Plan   Acute respiratory failure with hypoxia Due to COVID-19/ Pneumonia and acute COPD exacerbation Management as mentioned below Required 2 L of oxygen on exertion on home o2 eval    Acute Exacerbation of COPD Pneumonia/ Bronchitis Previous PFTs: 12/9/2019 moderate severe obstruction with mild restriction Chest x-ray-atelectasis in the left lung base, normal procalcitonin but sputum cultures grew MRSA and Strep Started on antibiotics Omnicef and Doxy and cont at dc Cont Duoneb, Symbicort. Decadron to complete the course Incentive spirometry every 4, Mucinex twice daily, Tessalon 100 mg as needed Cont home CPAP    Covid-19 Virus Infection Date of onset of symptoms: 1/25/2023 Symptoms present on admission: Cough, Dyspnea, fatigue Date of covid positive test: 1/25/2023, rapid test at facility.  Requested copy of the test Vaccination status: vaccinated Imaging: Mild atelectasis/infiltrate with fluid suggested in the left lung base.  Oxygen requirements on admission: 2 L NC Current oxygen requirements: 2 L NC Medical therapy: steroids complete total of 7 days Ok to complete home paxlovid Consultants following: None at this time Anticipated special isolation end date: TBD  Lasix 20 mg x 1 given for dry lung strategy      BPH Abnormal urinalysis History of prostate cancer Complaining of burning, frequency and urgency in urination UA was sent after ceftriaxone, noted microscopic blood in the urine possibly due to UTI Complete antibiotics as mentioned above  History of PAF Not on rate controlling medicines, continue Eliquis  OSA Continue CPAP
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive airways disorder, Pollakiuria, Procalcitonin normal, SARS-CoV-2 test positive, Sputum culture positive
Clinical narrative: Patient is a 89 y.o. male patient of MD with history of COPD, morbid obesity, PAF, prostate cancer, OSA on CPAP presented to Hospital with shortness of breath . Assessment and Plan   Acute respiratory failure with hypoxia Due to COVID-19/ Pneumonia and acute COPD exacerbation Management as mentioned below Required 2 L of oxygen on exertion on home o2 eval    Acute Exacerbation of COPD Pneumonia/ Bronchitis Previous PFTs: 12/9/2019 moderate severe obstruction with mild restriction Chest x-ray-atelectasis in the left lung base, normal procalcitonin but sputum cultures grew MRSA and Strep Started on antibiotics Omnicef and Doxy and cont at dc Cont Duoneb, Symbicort. Decadron to complete the course Incentive spirometry every 4, Mucinex twice daily, Tessalon 100 mg as needed Cont home CPAP    Covid-19 Virus Infection Date of onset of symptoms: 1/25/2023 Symptoms present on admission: Cough, Dyspnea, fatigue Date of covid positive test: 1/25/2023, rapid test at facility.  Requested copy of the test Vaccination status: vaccinated Imaging: Mild atelectasis/infiltrate with fluid suggested in the left lung base.  Oxygen requirements on admission: 2 L NC Current oxygen requirements: 2 L NC Medical therapy: steroids complete total of 7 days Ok to complete home paxlovid Consultants following: None at this time Anticipated special isolation end date: TBD  Lasix 20 mg x 1 given for dry lung strategy      BPH Abnormal urinalysis History of prostate cancer Complaining of burning, frequency and urgency in urination UA was sent after ceftriaxone, noted microscopic blood in the urine possibly due to UTI Complete antibiotics as mentioned above  History of PAF Not on rate controlling medicines, continue Eliquis  OSA Continue CPAP
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Staphylococcus test positive, Streptococcus test positive, Urinary tract infection, Urine analysis abnormal
Clinical narrative: Patient is a 89 y.o. male patient of MD with history of COPD, morbid obesity, PAF, prostate cancer, OSA on CPAP presented to Hospital with shortness of breath . Assessment and Plan   Acute respiratory failure with hypoxia Due to COVID-19/ Pneumonia and acute COPD exacerbation Management as mentioned below Required 2 L of oxygen on exertion on home o2 eval    Acute Exacerbation of COPD Pneumonia/ Bronchitis Previous PFTs: 12/9/2019 moderate severe obstruction with mild restriction Chest x-ray-atelectasis in the left lung base, normal procalcitonin but sputum cultures grew MRSA and Strep Started on antibiotics Omnicef and Doxy and cont at dc Cont Duoneb, Symbicort. Decadron to complete the course Incentive spirometry every 4, Mucinex twice daily, Tessalon 100 mg as needed Cont home CPAP    Covid-19 Virus Infection Date of onset of symptoms: 1/25/2023 Symptoms present on admission: Cough, Dyspnea, fatigue Date of covid positive test: 1/25/2023, rapid test at facility.  Requested copy of the test Vaccination status: vaccinated Imaging: Mild atelectasis/infiltrate with fluid suggested in the left lung base.  Oxygen requirements on admission: 2 L NC Current oxygen requirements: 2 L NC Medical therapy: steroids complete total of 7 days Ok to complete home paxlovid Consultants following: None at this time Anticipated special isolation end date: TBD  Lasix 20 mg x 1 given for dry lung strategy      BPH Abnormal urinalysis History of prostate cancer Complaining of burning, frequency and urgency in urination UA was sent after ceftriaxone, noted microscopic blood in the urine possibly due to UTI Complete antibiotics as mentioned above  History of PAF Not on rate controlling medicines, continue Eliquis  OSA Continue CPAP
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Alcohol abuse, Blood creatinine increased, COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease
Clinical narrative: Per Admit HPI: "(Name withheld) is a 81 y.o. female patient of (name withheld) MD with history of COPD, hypertension, hypothyroidism, and hyperlipidemia presented with COVID.   Patient reports she started feeling unwell with body aches about 2 days ago and tested positive for covid yesterday and that is why she came into the ED.  Patient reports she has been SOB for a few years and that is not new for her.  She had her first two vaccines with the last one being a couple years ago, but she has not had any boosters.   In the ED vitals are as follows, temperature 98.2, blood pressure 143/84, heart rate 81, RR 18, and oxygen saturation of 99% on 2L NC. Labs results were significant for creatinine 1.53, H/H8.9/27.8. The rest of the CBC and CMP were within normal limits. Troponin negative. Chest x-ray showed no change in the right upper lung scarring. CT pulmonary arteries showed no acute PE, aortic dissection, or other acute cardiopulmonary findings, COPD with several scattered foci of mild pulmonary parenchymal scarring, most prominent in the right upper lobe surrounding a surgical clip, unchanged. Patient was given dexamethasone and symbicort. Patient admitted for observation."   Clinical Summary Patient was admitted to hospital and treated with supplemental oxygen.  She maintain sats greater 90% on her home dose of 2 L.  Once confirmed that she is already on home oxygen her remdesivir was stopped.  She was treated with dexamethasone and will complete course at discharge.  She was also started on Mucinex, vitamin C, vitamin D, and zinc which will be continued at discharge.  She will continue her home Symbicort and Spiriva.  Anemia profile was obtained and was unremarkable.  Prescription for p.o. ferrous sulfate was provided as patient ran out.     Patient was seen and examined on day of discharge and is safe for discharge to home.  Patient states that she is feeling much better and is ready to go home today.  Labs and vital signs reviewed and are stable. Discharge instructions were provided to patient and all questions were answered. Patient is to follow-up with PCP in 5 to 7 days.    Discharge diagnosis COVID Chronic Hypoxic Respiratory Failure Hyponatremia Normocytic anemia COPD HTN HLD Hypothyroidism Alcohol Abuse
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Computerised tomogram thorax abnormal, Condition aggravated, Dyspnoea, Full blood count normal
Clinical narrative: Per Admit HPI: "(Name withheld) is a 81 y.o. female patient of (name withheld) MD with history of COPD, hypertension, hypothyroidism, and hyperlipidemia presented with COVID.   Patient reports she started feeling unwell with body aches about 2 days ago and tested positive for covid yesterday and that is why she came into the ED.  Patient reports she has been SOB for a few years and that is not new for her.  She had her first two vaccines with the last one being a couple years ago, but she has not had any boosters.   In the ED vitals are as follows, temperature 98.2, blood pressure 143/84, heart rate 81, RR 18, and oxygen saturation of 99% on 2L NC. Labs results were significant for creatinine 1.53, H/H8.9/27.8. The rest of the CBC and CMP were within normal limits. Troponin negative. Chest x-ray showed no change in the right upper lung scarring. CT pulmonary arteries showed no acute PE, aortic dissection, or other acute cardiopulmonary findings, COPD with several scattered foci of mild pulmonary parenchymal scarring, most prominent in the right upper lobe surrounding a surgical clip, unchanged. Patient was given dexamethasone and symbicort. Patient admitted for observation."   Clinical Summary Patient was admitted to hospital and treated with supplemental oxygen.  She maintain sats greater 90% on her home dose of 2 L.  Once confirmed that she is already on home oxygen her remdesivir was stopped.  She was treated with dexamethasone and will complete course at discharge.  She was also started on Mucinex, vitamin C, vitamin D, and zinc which will be continued at discharge.  She will continue her home Symbicort and Spiriva.  Anemia profile was obtained and was unremarkable.  Prescription for p.o. ferrous sulfate was provided as patient ran out.     Patient was seen and examined on day of discharge and is safe for discharge to home.  Patient states that she is feeling much better and is ready to go home today.  Labs and vital signs reviewed and are stable. Discharge instructions were provided to patient and all questions were answered. Patient is to follow-up with PCP in 5 to 7 days.    Discharge diagnosis COVID Chronic Hypoxic Respiratory Failure Hyponatremia Normocytic anemia COPD HTN HLD Hypothyroidism Alcohol Abuse
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, Hyperlipidaemia, Hypertension, Hyponatraemia
Clinical narrative: Per Admit HPI: "(Name withheld) is a 81 y.o. female patient of (name withheld) MD with history of COPD, hypertension, hypothyroidism, and hyperlipidemia presented with COVID.   Patient reports she started feeling unwell with body aches about 2 days ago and tested positive for covid yesterday and that is why she came into the ED.  Patient reports she has been SOB for a few years and that is not new for her.  She had her first two vaccines with the last one being a couple years ago, but she has not had any boosters.   In the ED vitals are as follows, temperature 98.2, blood pressure 143/84, heart rate 81, RR 18, and oxygen saturation of 99% on 2L NC. Labs results were significant for creatinine 1.53, H/H8.9/27.8. The rest of the CBC and CMP were within normal limits. Troponin negative. Chest x-ray showed no change in the right upper lung scarring. CT pulmonary arteries showed no acute PE, aortic dissection, or other acute cardiopulmonary findings, COPD with several scattered foci of mild pulmonary parenchymal scarring, most prominent in the right upper lobe surrounding a surgical clip, unchanged. Patient was given dexamethasone and symbicort. Patient admitted for observation."   Clinical Summary Patient was admitted to hospital and treated with supplemental oxygen.  She maintain sats greater 90% on her home dose of 2 L.  Once confirmed that she is already on home oxygen her remdesivir was stopped.  She was treated with dexamethasone and will complete course at discharge.  She was also started on Mucinex, vitamin C, vitamin D, and zinc which will be continued at discharge.  She will continue her home Symbicort and Spiriva.  Anemia profile was obtained and was unremarkable.  Prescription for p.o. ferrous sulfate was provided as patient ran out.     Patient was seen and examined on day of discharge and is safe for discharge to home.  Patient states that she is feeling much better and is ready to go home today.  Labs and vital signs reviewed and are stable. Discharge instructions were provided to patient and all questions were answered. Patient is to follow-up with PCP in 5 to 7 days.    Discharge diagnosis COVID Chronic Hypoxic Respiratory Failure Hyponatremia Normocytic anemia COPD HTN HLD Hypothyroidism Alcohol Abuse
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypothyroidism, Laboratory test normal, Malaise, Medical device site scar, Metabolic function test normal
Clinical narrative: Per Admit HPI: "(Name withheld) is a 81 y.o. female patient of (name withheld) MD with history of COPD, hypertension, hypothyroidism, and hyperlipidemia presented with COVID.   Patient reports she started feeling unwell with body aches about 2 days ago and tested positive for covid yesterday and that is why she came into the ED.  Patient reports she has been SOB for a few years and that is not new for her.  She had her first two vaccines with the last one being a couple years ago, but she has not had any boosters.   In the ED vitals are as follows, temperature 98.2, blood pressure 143/84, heart rate 81, RR 18, and oxygen saturation of 99% on 2L NC. Labs results were significant for creatinine 1.53, H/H8.9/27.8. The rest of the CBC and CMP were within normal limits. Troponin negative. Chest x-ray showed no change in the right upper lung scarring. CT pulmonary arteries showed no acute PE, aortic dissection, or other acute cardiopulmonary findings, COPD with several scattered foci of mild pulmonary parenchymal scarring, most prominent in the right upper lobe surrounding a surgical clip, unchanged. Patient was given dexamethasone and symbicort. Patient admitted for observation."   Clinical Summary Patient was admitted to hospital and treated with supplemental oxygen.  She maintain sats greater 90% on her home dose of 2 L.  Once confirmed that she is already on home oxygen her remdesivir was stopped.  She was treated with dexamethasone and will complete course at discharge.  She was also started on Mucinex, vitamin C, vitamin D, and zinc which will be continued at discharge.  She will continue her home Symbicort and Spiriva.  Anemia profile was obtained and was unremarkable.  Prescription for p.o. ferrous sulfate was provided as patient ran out.     Patient was seen and examined on day of discharge and is safe for discharge to home.  Patient states that she is feeling much better and is ready to go home today.  Labs and vital signs reviewed and are stable. Discharge instructions were provided to patient and all questions were answered. Patient is to follow-up with PCP in 5 to 7 days.    Discharge diagnosis COVID Chronic Hypoxic Respiratory Failure Hyponatremia Normocytic anemia COPD HTN HLD Hypothyroidism Alcohol Abuse
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Normocytic anaemia, Pain, Pulmonary fibrosis, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Per Admit HPI: "(Name withheld) is a 81 y.o. female patient of (name withheld) MD with history of COPD, hypertension, hypothyroidism, and hyperlipidemia presented with COVID.   Patient reports she started feeling unwell with body aches about 2 days ago and tested positive for covid yesterday and that is why she came into the ED.  Patient reports she has been SOB for a few years and that is not new for her.  She had her first two vaccines with the last one being a couple years ago, but she has not had any boosters.   In the ED vitals are as follows, temperature 98.2, blood pressure 143/84, heart rate 81, RR 18, and oxygen saturation of 99% on 2L NC. Labs results were significant for creatinine 1.53, H/H8.9/27.8. The rest of the CBC and CMP were within normal limits. Troponin negative. Chest x-ray showed no change in the right upper lung scarring. CT pulmonary arteries showed no acute PE, aortic dissection, or other acute cardiopulmonary findings, COPD with several scattered foci of mild pulmonary parenchymal scarring, most prominent in the right upper lobe surrounding a surgical clip, unchanged. Patient was given dexamethasone and symbicort. Patient admitted for observation."   Clinical Summary Patient was admitted to hospital and treated with supplemental oxygen.  She maintain sats greater 90% on her home dose of 2 L.  Once confirmed that she is already on home oxygen her remdesivir was stopped.  She was treated with dexamethasone and will complete course at discharge.  She was also started on Mucinex, vitamin C, vitamin D, and zinc which will be continued at discharge.  She will continue her home Symbicort and Spiriva.  Anemia profile was obtained and was unremarkable.  Prescription for p.o. ferrous sulfate was provided as patient ran out.     Patient was seen and examined on day of discharge and is safe for discharge to home.  Patient states that she is feeling much better and is ready to go home today.  Labs and vital signs reviewed and are stable. Discharge instructions were provided to patient and all questions were answered. Patient is to follow-up with PCP in 5 to 7 days.    Discharge diagnosis COVID Chronic Hypoxic Respiratory Failure Hyponatremia Normocytic anemia COPD HTN HLD Hypothyroidism Alcohol Abuse
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin normal
Clinical narrative: Per Admit HPI: "(Name withheld) is a 81 y.o. female patient of (name withheld) MD with history of COPD, hypertension, hypothyroidism, and hyperlipidemia presented with COVID.   Patient reports she started feeling unwell with body aches about 2 days ago and tested positive for covid yesterday and that is why she came into the ED.  Patient reports she has been SOB for a few years and that is not new for her.  She had her first two vaccines with the last one being a couple years ago, but she has not had any boosters.   In the ED vitals are as follows, temperature 98.2, blood pressure 143/84, heart rate 81, RR 18, and oxygen saturation of 99% on 2L NC. Labs results were significant for creatinine 1.53, H/H8.9/27.8. The rest of the CBC and CMP were within normal limits. Troponin negative. Chest x-ray showed no change in the right upper lung scarring. CT pulmonary arteries showed no acute PE, aortic dissection, or other acute cardiopulmonary findings, COPD with several scattered foci of mild pulmonary parenchymal scarring, most prominent in the right upper lobe surrounding a surgical clip, unchanged. Patient was given dexamethasone and symbicort. Patient admitted for observation."   Clinical Summary Patient was admitted to hospital and treated with supplemental oxygen.  She maintain sats greater 90% on her home dose of 2 L.  Once confirmed that she is already on home oxygen her remdesivir was stopped.  She was treated with dexamethasone and will complete course at discharge.  She was also started on Mucinex, vitamin C, vitamin D, and zinc which will be continued at discharge.  She will continue her home Symbicort and Spiriva.  Anemia profile was obtained and was unremarkable.  Prescription for p.o. ferrous sulfate was provided as patient ran out.     Patient was seen and examined on day of discharge and is safe for discharge to home.  Patient states that she is feeling much better and is ready to go home today.  Labs and vital signs reviewed and are stable. Discharge instructions were provided to patient and all questions were answered. Patient is to follow-up with PCP in 5 to 7 days.    Discharge diagnosis COVID Chronic Hypoxic Respiratory Failure Hyponatremia Normocytic anemia COPD HTN HLD Hypothyroidism Alcohol Abuse
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: RECEIVED ADDITIONAL BOOSTER DOSE OF MONOVALENT VACCINE ON 8/10/22.  VACCINE RECORD FOR MONOVALENT DOSE ON 7/7/22 WAS NOT IN RECORD WHEN DOSE FOR 8/10 CLINIC WAS APPROVED.